The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV)

http://clinicaltrials.gov/ct2/show/NCT00279201?term=%22Eli+Lilly+and+Company%22&rank=23

This study has been completed and has results

Sponsor: Eli Lilly and Company

Information provided by: Eli Lilly and Company

ClinicalTrials.gov Identifier: NCT00279201

First received: December 15, 2005

Last updated: January 24, 2011

Last verified: January 2011

   




Visual Summary created by WebSummarizer